Please try another search
Conduit Pharmaceuticals Inc., a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis and Grave’s disease, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. The company was founded in 2019 and is based in San Diego, California. Conduit Pharmaceuticals Limited is a subsidiary of Corvus Capital Limited.
Name | Age | Since | Title |
---|---|---|---|
Freda C. Lewis-Hall | 69 | 2023 | Independent Chairman of the Board |
David Joszef Tapolczay | 65 | 2023 | CEO & Director |
Faith L. Charles | - | 2023 | Independent Director |
Chele Chiavacci Farley | 56 | - | Independent Director |
Andrew Regan | 57 | 2023 | Director |
James Bligh | 35 | 2023 | CFO & Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review